# E-DRUG: Formulary and essential drug list

**URL:** <https://talk.edrugplus.org/t/e-drug-formulary-and-essential-drug-list/6277>\
**Category:** e-drug\
**Created:** [October 11, 1999, 9:54pm UTC](https://talk.edrugplus.org/t/e-drug-formulary-and-essential-drug-list/6277 "1999-10-11T21:54:14Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![Jody\_Dalmacion](https://avatars.discourse-cdn.com/v4/letter/j/9dc877/32.png) [@Jody\_Dalmacion](https://talk.edrugplus.org/u/Jody_Dalmacion)\
**Post date:** [October 11, 1999, 9:54pm UTC](https://talk.edrugplus.org/t/e-drug-formulary-and-essential-drug-list/6277/1 "1999-10-11T21:54:14Z")

</div>

E-drug: Formulary and essential drug list  
---------------------------------------------  
Greetings from Manila, Philippines and from a new  
member of e-drug. My subscription to e-drug was  
triggered by a need to consult with other people  
working with concerns like essential drugs and PTC.  
I was given the task to chair a committee that will  
update our present hospital formulary and I really  
don't know how to proceed for the simple reason that I  
have strong reservations about formularies whose drug  
list is govern by limitations in financial resources  
rather than by rationality of choices or scientific  
evidence.The hospital I work in is the premier  
teaching hospital in the country, the Philippine  
General Hospital, whose formulary has always been a  
model for other hospitals). But, I feel that the prime  
reason for choosing our drugs is not on sound  
scientific facts distinctive to our population but  
more as a result of research and literature reviews  
of experiences of other groups of people which may not  
be identical to ours. How do we balance this? What  
really should go into the decision tree when choosing  
one's essential drug list? How often should we change  
the formulary? What should our course of action be  
towards requests of our specialists for a preferred  
drug? I would really appreciate any inputs( by the way

I read A. Gray reply to Dr. W. Qin (?) query with  
interest).

Many thanks and I look forward to interesting  
exchanges.

Jody Dalmacion  
jrvd1953@yahoo.com  
fax 0632 521 8251  
[Manually added by BS]  
[Please always include your physical address and affiliation. BS.]

--  
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.  
Mail administrative requests to `majordomo@usa.healthnet.org'.  
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.
